🚀 VC round data is live in beta, check it out!
Anhui Huaheng Valuation Multiples
Discover revenue and EBITDA valuation multiples for Anhui Huaheng and similar public comparables like Corbion, CVR Partners, Takara Bio, SunOpta and more.
Anhui Huaheng Overview
About Anhui Huaheng
Anhui Huaheng Biotechnology Co Ltd is engaged in the research and development, production and sales of bio-based products such as amino acids and other alanine products.
Founded
2005
HQ
Employees
N/A
Website
Financials (LTM)
EV
$1B
Anhui Huaheng Financials
Anhui Huaheng reported last 12-month revenue of $439M and EBITDA of $79M.
In the same LTM period, Anhui Huaheng generated $106M in gross profit, $79M in EBITDA, and $37M in net income.
Revenue (LTM)
Anhui Huaheng P&L
In the most recent fiscal year, Anhui Huaheng reported revenue of $315M and EBITDA of $55M.
Anhui Huaheng expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $439M | XXX | $315M | XXX | XXX | XXX |
| Gross Profit | $106M | XXX | $79M | XXX | XXX | XXX |
| Gross Margin | 24% | XXX | 25% | XXX | XXX | XXX |
| EBITDA | $79M | XXX | $55M | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 17% | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $37M | XXX | $27M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 9% | XXX | XXX | XXX |
| Net Debt | — | — | $130M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Anhui Huaheng Stock Performance
Anhui Huaheng has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Anhui Huaheng's stock price is $4.96.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | (0.2%) | XXX | XXX | XXX | $0.11 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAnhui Huaheng Valuation Multiples
Anhui Huaheng trades at 3.4x EV/Revenue multiple, and 18.7x EV/EBITDA.
EV / Revenue (LTM)
Anhui Huaheng Financial Valuation Multiples
As of March 11, 2026, Anhui Huaheng has market cap of $1B and EV of $1B.
Equity research analysts estimate Anhui Huaheng's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Anhui Huaheng has a P/E ratio of 33.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 3.4x | XXX | 4.7x | XXX | XXX | XXX |
| EV/EBITDA | 18.7x | XXX | 26.9x | XXX | XXX | XXX |
| EV/EBIT | 37.3x | XXX | 45.6x | XXX | XXX | XXX |
| EV/Gross Profit | 13.8x | XXX | 18.7x | XXX | XXX | XXX |
| P/E | 33.7x | XXX | 45.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (14.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Anhui Huaheng Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Anhui Huaheng Margins & Growth Rates
Anhui Huaheng's revenue in the last 12 month grew by 23%.
Anhui Huaheng's rule of 40 is 41% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Anhui Huaheng's rule of X is 76% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Anhui Huaheng Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 23% | XXX | 33% | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | 29% | XXX | 36% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 41% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 76% | XXX | XXX | XXX |
| S&M Expenses to Revenue | 3% | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 7% | XXX | 6% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 5% | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 15% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Anhui Huaheng Public Comps
See public comps and valuation multiples for other Bioindustrials comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Corbion | XXX | XXX | XXX | XXX | XXX | XXX |
| CVR Partners | XXX | XXX | XXX | XXX | XXX | XXX |
| Takara Bio | XXX | XXX | XXX | XXX | XXX | XXX |
| SunOpta | XXX | XXX | XXX | XXX | XXX | XXX |
| Gujarat State Fertilizers | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Anhui Huaheng M&A Activity
Anhui Huaheng acquired XXX companies to date.
Last acquisition by Anhui Huaheng was on XXXXXXXX, XXXXX. Anhui Huaheng acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Anhui Huaheng
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAnhui Huaheng Investment Activity
Anhui Huaheng invested in XXX companies to date.
Anhui Huaheng made its latest investment on XXXXXXXX, XXXXX. Anhui Huaheng invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Anhui Huaheng
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Anhui Huaheng
| When was Anhui Huaheng founded? | Anhui Huaheng was founded in 2005. |
| Where is Anhui Huaheng headquartered? | Anhui Huaheng is headquartered in China. |
| Is Anhui Huaheng publicly listed? | Yes, Anhui Huaheng is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of Anhui Huaheng? | Anhui Huaheng trades under 688639 ticker. |
| When did Anhui Huaheng go public? | Anhui Huaheng went public in 2021. |
| Who are competitors of Anhui Huaheng? | Anhui Huaheng main competitors are Corbion, CVR Partners, Takara Bio, SunOpta. |
| What is the current market cap of Anhui Huaheng? | Anhui Huaheng's current market cap is $1B. |
| What is the current revenue of Anhui Huaheng? | Anhui Huaheng's last 12 months revenue is $439M. |
| What is the current revenue growth of Anhui Huaheng? | Anhui Huaheng revenue growth (NTM/LTM) is 23%. |
| What is the current EV/Revenue multiple of Anhui Huaheng? | Current revenue multiple of Anhui Huaheng is 3.4x. |
| Is Anhui Huaheng profitable? | Yes, Anhui Huaheng is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Anhui Huaheng? | Anhui Huaheng's last 12 months EBITDA is $79M. |
| What is Anhui Huaheng's EBITDA margin? | Anhui Huaheng's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Anhui Huaheng? | Current EBITDA multiple of Anhui Huaheng is 18.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.